Inovio Pharmaceuticals (INO) Stock: 5 Reasons To Buy Despite The VGX-3100 Delay

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio shareholders were met with some unexpected news on Monday when the company announced that the FDA has requested additional information regarding the disposable elements of it proprietary Cellectra 5PSP immunotherapy delivery device. Trade smarter and make more money with Tradespoon! In a statement from the company, Inovio stated,”“Inovio is working … Read more

Inovio Pharmaceuticals (INO) Stock: Here’s Why It’s Falling!

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals started the day off with big declines today, and for good reason. The company announced that a clinical hold has been placed on one of its clinical programs. Today, we’ll talk about what we’re seeing from the stock, the clinical hold, and later today, Kenny Soulstring will weigh … Read more

Inovio Pharmaceuticals (INO) Climbs On Preclinical Testing

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals is having an incredible day in the market today after making a big early morning announcement. The company announced key results from the preclinical testing phase of a vaccine that is much needed in the medical industry. Today, we’ll talk about the preclinical testing results, how the market … Read more

Inovio Pharmaceuticals (INO) Stock: Should You Be Concerned About Declines?

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals is having a rough start to the week in the market today. However, this follows a strong day in the market on Friday. With the positive news surrounding the stock, should investors really be concerned about today’s declines? Today, we’ll talk about what we saw on Friday that … Read more

Inovio Pharmaceuticals (INO) Stock Climbs On Recruitment

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals had a great day in the market yesterday. However, yesterday’s 8% climb is nothing compared to what we’re seeing in the market today. Earlier this morning, INO announced that it is starting patient recruitment with regard to a study and investors are proving to be excited. Today, we’ll … Read more

Today In Biotech: iBio (IBIO), Inovio Pharmaceuticals (INO), Novavax (NVAX), MannKind (MNKD)

iBio Climbs On US Patent Approval iBio Inc (NYSEMKT: IBIO) iBio is having an incredible day in the market today after announcing that it has received a notice from the US patent office with regard to its application for a monoclonal antibody designed to target influenza. According to the announcement, the new patent will become … Read more

Inovio Pharmaceuticals (INO) Declines: Why Bulls Aren’t Concerned

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals had an incredible day in the market yesterday. Not only did the company beat earnings expectations, it announced a deal with AstraZeneca that has the potential to drive more than $700 million in revenue. However, today is a completely different story. Unfortunately, the stock is seeing declines. So … Read more

Today In Biotech: MannKind (MNKD), Inovio Pharmaceuticals (INO), Amarin (AMRN), Gilead Sciences (GILD)

MannKind Beats Earnings Expectations & Excites Investors With Great News MannKind Corporation (NASDAQ:MNKD) MannKind is having an incredible day in the market today after releasing a slew of positive news. First and foremost, the company beat earnings expectations; producing a loss of $0.07 which was $0.01 ahead of earnings expectations. However, that wasn’t even the … Read more

Inovio Pharmaceuticals Beats Earnings & Announces Acquisition

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals is having an incredible day in the market today after reporting incredible financial data and announcing that it has entered into a license agreement with AstraZeneca (NYSE: AZN) for the acquisition of rights to INO-3112. Here are the details… Inovio Pharmaceuticals Blows Earnings Expectations Out Of The Water! … Read more